Advanced search
Publication Cover
Journal of Addictive Diseases Volume 24, 2005 - Issue 3
Submit an article Journal homepage
144
Views
39
CrossRef citations to date
0
Altmetric
Original Articles

Methadone Dosage and Retention

An Examination of the 60 mg/Day Threshold

Thomas M. Brady PhD Substance Abuse and Mental Health Services Administration (SAMHSA)
,
Sameena Salvucci PhD the Synectics for Management Decisions,Inc., 1901 North Moore Street, Suite 900, Arlington, VA, 22209, USA
,
Lev S. Sverdlov MD, PhD the Synectics for Management Decisions,Inc., 1901 North Moore Street, Suite 900, Arlington, VA, 22209, USA
,
Alisa Male MA the Synectics for Management Decisions,Inc., 1901 North Moore Street, Suite 900, Arlington, VA, 22209, USA
,
Hannah Kyeyune MA the Synectics for Management Decisions,Inc., 1901 North Moore Street, Suite 900, Arlington, VA, 22209, USA
,
Emmanuel Sikali MA the Synectics for Management Decisions,Inc., 1901 North Moore Street, Suite 900, Arlington, VA, 22209, USA
,
Sameer Desale MA the Synectics for Management Decisions,Inc., 1901 North Moore Street, Suite 900, Arlington, VA, 22209, USA
&
Ping Yu MA the Synectics for Management Decisions,Inc., 1901 North Moore Street, Suite 900, Arlington, VA, 22209, USA
 show all
Pages 23-47 | Published online: 17 Oct 2008
 
Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days

Abstract

A National Institutes of Health (NIH) expert panel has mentioned a daily methadone dose of at least 60 mg as a best practice in methadone maintenance. The focus of this research is to estimate the percentage of outpatient methadone clients receiving this level of methadone and examine the association between treatment retention and level of methadone dosage as recommended by the NIH expert panel. A sample of 428 methadone clients discharged from methadone treatment facilities from the Alcohol and Drug Services Study (ADSS) was used, representing 109,973 methadone clients nationally. It was estimated that more than two-thirds of methadone clients nationally were receiving below 60 mg/day. While controlling for a number of client and organizational variables, a daily methadone dose of 60 mg/day or above was found to be associated with longer retention in treatment. Exploring factors affecting the utilization of the recommended daily methadone dose remains an important issue in effective delivery of methadone treatment.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Efficacy of disulfiram: a reply to Hughes and Cook.
Source: Wiley
Race and medicine.
Source: American Association for the Advancement of Science (AAAS)
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis
Source: Elsevier BV
Growing Implications for Primary Care
Source: American Medical Association (AMA)
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
Source: American Medical Association (AMA)
Chart Reviews In Emergency Medicine Research: Where Are The Methods?
Source: Elsevier BV
Version 5
Source: ICPSR - Interuniversity Consortium for Political and Social Research
Exposure to Methadone Programs and Heroin Use
Source: Informa UK Limited
Methadone maintenance. Does dose determine differences in outcome
Source: Elsevier BV
Methadone dose and heroin use during maintenance treatment
Source: Wiley
Validity of self-reports and drug use among young people seeking treatment for substance abuse or dependence.
Source: Informa UK Limited
EFFECTIVENESS OF METHADONE MAINTENANCE FOR HEROIN ADDICTION
Source: SAGE Publications
Variations in methadone treatment practices. Results from a national study
Source: American Medical Association (AMA)
The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
Source: Springer Science and Business Media LLC
Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care.
Source: Wiley
A Randomized Controlled Trial
Source: American Medical Association (AMA)
SUBSTITUTION THERAPY FOR HEROIN ADDICTION
Source: Informa UK Limited
A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
Source: American Medical Association (AMA)
History and current status of opioid maintenance treatments: blending conference session
Source: Elsevier BV
Drug Prices and Emergency Department Mentions for Cocaine and Heroin
Source: American Public Health Association
A Randomized Trial
Source: American Medical Association (AMA)
Patterns of service use and treatment involvement of methadone maintenance patients
Source: Elsevier BV
Effective medical treatment of opiate addiction
Source: American Medical Association (AMA)
A controlled trial of buprenorphine treatment for opioid dependence
Source: American Medical Association (AMA)
Results From a National Panel Study, 1988-2000
Source: American Medical Association (AMA)
The validity of self-reports in a follow-up study with drug addicts.
Source: Elsevier BV
Methadone Maintenance and Needle-Exchange Programs to Reduce the Medical and Public Health Consequences of Drug Abuse
Source: Informa UK Limited
Self‐reports by alcohol and drug abuse inpatients: factors affecting reliability and validity
Source: Wiley
The importance of race and ethnic background in biomedical research and clinical practice.
Source: Massachusetts Medical Society
Pre- and in-treatment predictors of retention in methadone treatment using survival analysis
Source: Wiley
Race, ethnic group, and clinical research
Source: BMJ

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.